BioNTech SE annual operating expenses
2017
2018
2019
2020
2021
2022
2023
2024
2025
BioNTech SE Operating Expenses Growth & History (BNTX)
BioNTech SE's operating expenses was €3.63B for fiscal 2025.
View full BioNTech SE company overviewBioNTech SE annual operating expenses history
| Fiscal year | Period ended | Operating expenses | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | €3.63B | €108.9M | +3.09% |
| 2024 | 2024-12-31 | €3.52B | €995.3M | +39.36% |
| 2023 | 2023-12-31 | €2.53B | €855.9M | +51.16% |
| 2022 | 2022-12-31 | €1.67B | €891.5M | +114.09% |
| 2021 | 2021-12-31 | €781.4M | €276.0M | +54.61% |
| 2020 | 2020-12-31 | €505.4M | €232.7M | +85.31% |
| 2019 | 2019-12-31 | €272.7M | €105.0M | +62.59% |
| 2018 | 2018-12-31 | €167.7M | €54.2M | +47.71% |
| 2017 | 2017-12-31 | €113.6M | — | — |
BioNTech SE quarterly operating expenses
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Operating expenses | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | €947.3M | €290.9M | +44.32% |
| Q1 2026 | 2026-03-31 | €717.9M | — | — |
| Q4 2025 | 2025-12-31 | €854.6M | — | — |
| Q3 2025 | 2025-09-30 | €716.7M | — | — |
| Q2 2025 | 2025-06-30 | €656.4M | — | — |
BioNTech SE operating expenses trends
Over the last five fiscal years, BioNTech SE's operating expenses increased from €505.4M to €3.63B, a change of €3.13B. The latest reported quarter, Q2 2026, shows €947.3M.
About the metric
What operating expenses mean
Operating expenses are the recurring costs of running a company’s business beyond the direct costs used to calculate gross profit. They commonly include selling, general and administrative expenses, research and development, and other operating costs.
Calculation and source
SEC-reported and calculated operating expenses
TickerStat uses operating expenses reported in company SEC filings when available. When a separate total is unavailable, it calculates operating expenses as aligned gross profit minus operating income for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review BioNTech SE source filings ↗